Recommended expert
Michal Konstacky
Managing Director/Consultant
Experience
Mar 2023 - Present
2 years 11 monthsSwitzerland
Managing Director/Consultant
K Medical Consulting GmbH
- Consulted for AstraZeneca (Forxiga: chronic renal & heart failure, T2DM)
- Consulted for Pfizer (ATTR cardiomyopathy registry)
- Consulted for Merck (rare diseases, BD/due diligence)
- Consulted for Idorsia (daridorexant: insomnia PIP, cenerimode: SLE safety physician)
- Consulted for PrimeVigilance (ovarian cancer)
- Reviewed EU scientific grants for the Czech Ministry of Education
- Member of the evaluating committee for the Czech Academy of Sciences
- Served as CMO in device & biotech startups (Sherpa Healthcare, HTG Medical, C-mo)
Jun 2021 - Feb 2023
1 year 9 monthsBasel, Switzerland
Senior Medical Director
Luzsana
- Led global Phase I–III clinical programs in diabetes, Alzheimer’s, and eosinophilic esophagitis
- Managed a cross-functional team of 60 across China, the US, and EU
- Delivered regulatory strategies and human factor studies for drug-device combination products
Sep 2020 - May 2021
9 monthsBasel, Switzerland
Global Medical Director
Roche
- Oversaw early-stage clinical trials for Angelman syndrome and Dup15q syndrome (Phase IIa, proof of concept)
- Led development of the medical section for the End-of-Phase I briefing book for FDA Project Management meeting
- Organized two advisory boards
- Served as Governance Reform Squad Leader for pRED
Sep 2019 - Aug 2020
1 yearZürich, Switzerland
Global Medical Director
Takeda
- Oversaw the SHP647 program for Crohn’s disease and ulcerative colitis under supervision of the European Committee
- Developed a Phase II program in primary sclerosing cholangitis (PSC)
- Orchestrated publications in leading journals (e.g., Lancet, NEJM)
- Chaired advisory boards and integrated patient input into study design
- Managed global drug and device launches
Sep 2018 - Jul 2019
11 monthsZürich, Switzerland
Senior Director
Aegerion
- Led cross-functional teams of up to 60 in multinational settings
- Managed a 17-member EU patient advocacy team
- Led the EU launch of metreleptin for rare metabolic disorders
- Developed medical information and pharmacovigilance infrastructure
- Established a patient registry
- Organized advisory boards
- Orchestrated three clinical trials in lipodystrophy
Jun 2014 - Aug 2018
4 years 3 monthsZug, Switzerland
Global Medical Affairs Director
Shire
- Led programs for Hunter syndrome (MPS II) and other lysosomal storage disorders (MPS IIIa, MLD)
- Prepared regulatory submissions
- Organized advisory boards
- Managed safety reporting, including the HOS registry
- Directed the launch of the intrathecal program (Hunter IT)
Sep 2012 - May 2014
1 year 9 monthsZürich, Switzerland
EMEA Medical Head
Aerocrine
- Launched FeNO devices for asthma diagnostics
- Negotiated with payors and regulators
- Built and trained medical teams in Europe, China, and Japan
Apr 2010 - Aug 2012
2 years 5 monthsZürich, Switzerland
Head of Respiratory Medical
Nycomed
- Managed pre-launch and launch activities of the medical team for respiratory drugs including roflumilast (COPD)
- Co-designed a €120 M COPD mortality study
- Collaborated with Orion Pharma (Finland)
Feb 2009 - Mar 2010
1 year 2 monthsBasel, Switzerland
International Medical Affairs Director
Solvay
- Developed global KOL strategies across therapy areas
- Co-chaired the OSCAR cardiometabolic trial publication board
- Coordinated the Metabolic Syndrome Institute, a collaborative project with the Joslin Diabetes Center at Harvard
Sep 2007 - Jan 2009
1 year 5 monthsBarcelona, Spain
International Medical Manager
Almirall
- Led pre-launch activities for aclidinium bromide in COPD
- Collaborated on human factor and lung deposition studies
- Partnered with Forest Laboratories for co-development efforts
Jan 2003 - Aug 2007
4 years 8 monthsPrague, Czech Republic
Medical & Safety Manager
AstraZeneca
- Oversaw cardiovascular, GI, and neuroscience portfolios, including major clinical trials and product launches
- Supervised pharmacovigilance operations (PSURs, RMPs)
- Ensured compliance with EMA and FDA regulations
- Supported the JUPITER trial (rosuvastatin) and MLR reviews as a nominated signatory
Sep 1995 - Dec 2002
7 years 4 monthsHradec Kralove, Czech Republic
Assistant Professor
Uni Hospital Hradec Kralove
- Taught and mentored medical students and residents in internal medicine, sport medicine, and cardiology
- Conducted research in cardiovascular diseases and supervised clinical trials as principal investigator
- Provided advanced diagnostic and therapeutic services, including echocardiography and GI endoscopy
- Supervised PhD theses on Helicobacter pylori inflammation and cardiovascular disorders
Summary
Accomplished physician and global leader with over 20 years in the pharmaceutical industry and 12+ years in academia and clinical practice.
Proven ability to lead large, diverse teams and align global strategies with local requirements.
Key therapeutic areas: Neurosciences, rare diseases, cardiometabolic, GI, immunology, and respiratory medicine.
Skills
- Medical Affairs: Driving Successful Product Launches Across Multiple Therapeutic Areas.
- Clinical Development: Designing And Executing Early- And Late-stage Trials, Leading Regulatory Submissions (Nda, Bla, Maa).
- Pharmacovigilance: Ensuring Compliance, Risk Management, And Patient Safety.
Languages
Czech
AdvancedEnglish
AdvancedPolish
AdvancedRussian
AdvancedSlovak
Advanced ...and 4 more
Education
Oct 2010 - Jun 2013
City University of Seattle
Master of Business Administration · Business Administration · Seattle, United States
Oct 1999 - Jun 2002
Charles University in Prague / Aarhus Uni, Denmark
PhD · Aarhus, Denmark
Oct 1989 - Jun 1995
Charles University in Prague
Doctor of Medicine · Medicine · Prague, Czech Republic · summa cum laude
Certifications & licenses
AI In Healthcare
MIT
Negotiation Mastery
Harvard
Internal Medicine Board Certified
Need a freelancer? Find your match in seconds.
Try FRATCH GPT More actions
Similar Freelancers
Discover other experts with similar qualifications and experience